公开(公告)号：DE69232409D1

公开(公告)日：2002-03-21

申请号：DE69232409

申请日：1992-11-12

Applicant: BAXTER INT

Inventor： JOHNSON DOUGLAS GILES ,  TITUS ALLAN EDWARD ,  JENKE DENNIS

IPC: A61K9/00 ,  A61K31/34 ,  A61K47/02 ,  A61K9/08 ,  A61K47/26 ,  A61P43/00 ,  A61K31/341

Abstract: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.

公开(公告)号：DE69232409T2

公开(公告)日：2002-11-07

申请号：DE69232409

申请日：1992-11-12

Applicant: BAXTER INT

Inventor： JOHNSON DOUGLAS GILES ,  TITUS ALLAN EDWARD ,  JENKE DENNIS

IPC: A61K9/00 ,  A61K31/34 ,  A61K9/08 ,  A61K47/02 ,  A61K47/26 ,  A61P43/00 ,  A61K31/341

Abstract: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.

公开(公告)号：AU654421B2

公开(公告)日：1994-11-03

申请号：AU3075192

申请日：1992-11-12

Applicant: BAXTER INT

Inventor： JOHNSON DOUGLAS GILES ,  JENKE DENNIS R ,  TITUS ALLAN EDWARD

IPC: A61K9/08 ,  A61K9/00 ,  A61K31/34 ,  A61K47/02 ,  A61K47/26 ,  A61P43/00

Abstract: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.